Artificial Intelligence (AI) in Healthcare

Artificial Intelligence (AI) in Healthcare

Global Artificial Intelligence (AI) in Healthcare Market to Reach $308.9 Billion by 2030
The global market for Artificial Intelligence (AI) in Healthcare estimated at US$36.3 Billion in the year 2023, is expected to reach US$308.9 Billion by 2030, growing at a CAGR of 35.8% over the analysis period 2023-2030. AI in Healthcare Software, one of the segments analyzed in the report, is expected to record a 37% CAGR and reach US$159.5 Billion by the end of the analysis period. Growth in the AI in Healthcare Hardware segment is estimated at 35.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12 Billion, While China is Forecast to Grow at 34.2% CAGR
The Artificial Intelligence (AI) in Healthcare market in the U.S. is estimated at US$12 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$49.8 Billion by the year 2030 trailing a CAGR of 34.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 32.2% and 30.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 24.8% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 222 Featured) -
  • Amazon Web Services (Aws)
  • Enlitic Inc.
  • General Electric Company
  • General Vision
  • Google
  • IBM Corporation
  • iCarbonX
  • Intel Corporation
  • Johnson & Johnson Services
  • Koninklijke Philips
  • Medtronic
  • Micron Technology
  • Microsoft Corporation
  • Next IT Corp.
  • Nvidia Corporation
  • Siemens Healthineers (A Strategic Unit Of Siemens Group)
  • Welltok Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Artificial Intelligence (AI) in Healthcare - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 4: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World 7-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World 7-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 10: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World 7-Year Perspective for Hospitals & Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World 7-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 15: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 16: World 7-Year Perspective for Pharmaceuticals & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Machine Learning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World 7-Year Perspective for Machine Learning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Natural Language Processing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World 7-Year Perspective for Natural Language Processing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 21: World Recent Past, Current & Future Analysis for Context-Aware Computing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 22: World 7-Year Perspective for Context-Aware Computing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Computer Vision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World 7-Year Perspective for Computer Vision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 25: World Artificial Intelligence (AI) in Healthcare Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Connected Machines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World 7-Year Perspective for Connected Machines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 30: World Recent Past, Current & Future Analysis for Fraud Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 31: World 7-Year Perspective for Fraud Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World 7-Year Perspective for Diagnosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Virtual Assistants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World 7-Year Perspective for Virtual Assistants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 36: World Recent Past, Current & Future Analysis for Dosage Error Reduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 37: World 7-Year Perspective for Dosage Error Reduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 41: World 7-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
TABLE 42: World Recent Past, Current & Future Analysis for Robot-Assisted Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 43: World 7-Year Perspective for Robot-Assisted Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 46: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 47: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 48: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 49: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: USA 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
CANADA
TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 53: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 54: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 55: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 58: Canada Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 59: Canada 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
JAPAN
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 61: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 64: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 65: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 66: Japan Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 67: Japan 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
CHINA
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 71: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 73: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: China 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
EUROPE
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 77: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 79: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 83: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 85: Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
FRANCE
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 89: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 91: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
GERMANY
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 95: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 97: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 101: Germany 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
ITALY
TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 103: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 107: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 109: Italy 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
UNITED KINGDOM
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 112: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 113: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 114: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 115: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
REST OF EUROPE
TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 119: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 120: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 121: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 125: Rest of Europe 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
ASIA-PACIFIC
Artificial Intelligence (AI) in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 127: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 131: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 133: Asia-Pacific 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
REST OF WORLD
TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2024 & 2030
TABLE 136: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by End-Use - Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 137: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by End-Use - Percentage Breakdown of Value Sales for Hospitals & Healthcare Providers, Patients, Pharmaceuticals & Biotechnology Companies, Healthcare Payers and Other End-Uses for the Years 2024 & 2030
TABLE 138: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Technology - Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 139: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Technology - Percentage Breakdown of Value Sales for Machine Learning, Natural Language Processing, Context-Aware Computing and Computer Vision for the Years 2024 & 2030
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence (AI) in Healthcare by Application - Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World 7-Year Perspective for Artificial Intelligence (AI) in Healthcare by Application - Percentage Breakdown of Value Sales for Connected Machines, Fraud Detection, Diagnosis, Virtual Assistants, Dosage Error Reduction, Other Applications, Clinical Trials and Robot-Assisted Surgery for the Years 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings